The pediatric Rome IV criteria: what's new?

Ilan J N Koppen1, Samuel Nurko2, Miguel Saps3

  • 1a Department of Pediatric Gastroenterology and Nutrition , Emma Children's Hospital /Academic Medical Center , Amsterdam , the Netherlands.

Insights

The revised Rome IV criteria offer improved diagnosis for pediatric functional gastrointestinal disorders (FGIDs). These updates refine infant colic criteria and introduce new FGID categories for children and adolescents.

Area of Science:

  • Pediatric Gastroenterology
  • Functional Gastrointestinal Disorders

Background:

  • Functional gastrointestinal disorders (FGIDs) are prevalent in children and diagnosed using symptom-based criteria.
  • FGIDs lack structural or biochemical abnormalities, presenting diagnostic challenges.

Purpose of the Study:

  • To review the revised pediatric Rome IV criteria for diagnosing FGIDs.
  • To highlight key changes in diagnostic criteria for neonates, toddlers, children, and adolescents.

Main Methods:

  • Review of the published pediatric Rome IV criteria (2016).
  • Analysis of revisions concerning infant colic, functional nausea, functional vomiting, and functional abdominal pain disorders.

Main Results:

  • Significant revisions were made to infant colic criteria for neonates/toddlers.
  • New FGID categories, functional nausea and functional vomiting, were defined for children/adolescents.
  • Restructured criteria for functional abdominal pain disorders, including subtypes of functional dyspepsia and irritable bowel syndrome.

Conclusions:

  • The Rome IV criteria represent a refinement in FGID diagnosis for pediatric populations.
  • These updated criteria are expected to enhance clinical differentiation and benefit future research and patient care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
628
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
586
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
655
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
1.1K